Literature DB >> 241876

[Effect of chronic beta-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author's transl)].

K O Stumpe, H Vetter, V Hessenbruch, R Düsing, R Kolloch, F Krück.   

Abstract

Blood pressure (BP), plasma renin activity (PRA) and plasma concentration of aldosterone (PA) and cortisol (PC) were determined in essential hypertensive patients before and after beta-adrenergic blockade with propranolol and prindolol. Serial measurements of PRA, PA and PC at 30 min intervals (8 p.m. to 6 a.m.) were performed in 8 patients. Administration of propranolol (50 mg three times daily) over a period of 4 weeks was followed by a significant reduction in BP, PRA and PA. PC remained unaltered. The pattern of rhythmic secretion of renin was abolished whereas that of aldosterone persisted at a lower level. Prindolol (10 mg three times daily) had a similar effect on BP as propranolol but failed to lower PRA and PA. Rhythmic secretion of renin was also markedly altered with prindolol in the absence of any change in rhythmicity of PA and PC. The hypotensive action of prindolol was not mediated via inhibition of renin release. The dissociation between PRA and PA rhythmicity indicates that during beta-adrenergic blockade diurnal rhythm of aldosterone secretion is not regulated by the renin-angiotensin-system. Rhythmicity of PC was normal, indicating that also ACTH-secretion was unaltered. Thus, under beta-blockade unchanged diurnal rhythm of aldosterone may be due to normal ACTH-secretion.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 241876     DOI: 10.1007/bf01468983

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  14 in total

1.  ELECTROLYTE EXCRETION IN RELATION TO DIURNAL CYCLES OF RENAL FUNCTION.

Authors:  L G WESSON
Journal:  Medicine (Baltimore)       Date:  1964-09       Impact factor: 1.889

2.  Effect of alprenolol on blood pressure and plasma renin activity in hypertensive patients.

Authors:  J Castenfors; H Johnsson; L Orö
Journal:  Acta Med Scand       Date:  1973-03

3.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

4.  The effect of chronic adrenergic receptor blockade on plasma renin activity in man.

Authors:  A M Michelakis; R G McAllister
Journal:  J Clin Endocrinol Metab       Date:  1972-02       Impact factor: 5.958

5.  Effect of practolol on blood pressure and renin release in man.

Authors:  M D Esler
Journal:  Clin Pharmacol Ther       Date:  1974-05       Impact factor: 6.875

6.  Radioimmunoassay for aldosterone without chromatography. 2. Determination of plasma aldosterone.

Authors:  W Vetter; H Vetter; W Siegenthaler
Journal:  Acta Endocrinol (Copenh)       Date:  1973-11

7.  Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.

Authors:  F R Bühler; J H Laragh; L Baer; E D Vaughan; H R Brunner
Journal:  N Engl J Med       Date:  1972-12-14       Impact factor: 91.245

8.  Central hypotensive activity of dl- and d-propranolol.

Authors:  G J Kelliher; J P Buckley
Journal:  J Pharm Sci       Date:  1970-09       Impact factor: 3.534

9.  Effect of stimulation of the medulla oblongata on renin secretion in dogs.

Authors:  S S Passo; T A Assaykeen; K Otsuka; B L Wise; A Goldfien; W F Ganong
Journal:  Neuroendocrinology       Date:  1971       Impact factor: 4.914

10.  Beta-blockers and plasma renin activity in hypertension.

Authors:  G S Stokes; M A Weber; I R Thornell
Journal:  Br Med J       Date:  1974-01-12
View more
  6 in total

Review 1.  Hypertension: which beta-blocker?

Authors:  H J Waal-Manning
Journal:  Drugs       Date:  1976-12       Impact factor: 9.546

Review 2.  Intrinsic sympathomimetic activity of beta-adrenoceptor blocking agents.

Authors:  G Cocco; F Burkart; D Chu; F Follath
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953

3.  Pharmacokinetics of atenolol in patients with renal impairment.

Authors:  J Sassard; N Pozet; J McAinsh; J Legheand; P Zech
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

4.  [Raised plasma-prolactin levels in essential hypertension: index of reduced hypothalamic dopaminergic activity (author's transl)].

Authors:  R Kolloch; K O Stumpe; M Higuchi; H Vetter; F Krück
Journal:  Klin Wochenschr       Date:  1977-10-15

5.  Renin, aldosterone and arterial pressure responses to acute beta-adrenergic receptor blockage in hypertensive patients.

Authors:  K O Stumpe; R Kolloch; W Gramann; H Vetter; C Ressel; M Higuchi; F Krück
Journal:  Klin Wochenschr       Date:  1976-08-15

6.  Decreased urinary kallikrein activity and elevated blood pressure normalized by orally applied kallikrein in essential hypertension.

Authors:  A Overlack; K O Stumpe; C Ressel; R Kolloch; W Zywzok; F Krück
Journal:  Klin Wochenschr       Date:  1980-01-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.